
Shenzhen
300942.SZShenzhen Bioeasy Biotechnology Co., Ltd. Price (300942.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
401,973,412
(0.2778)%
Cash Flow Statement
Shenzhen Bioeasy Biotechnology Co., Ltd.Currency: CNY
YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | 23.42M
+0% |
39.27M
+68% |
73.91M
+88% |
92.29M
+25% |
65.45M
-29% |
236.47M
+261% |
82.66M
-65% |
-184,983,355.31
-324% |
|||||||||||
Depreciation And Amortiz... | 3.49M | 42.88k | 63.74k | 163.03k | 5.52M | 24.16M | 30.36M | 33.48M | |||||||||||
Deferred Income Tax | 0.00 | 691.30k | -157,200.00 | 818.28k | -2,668,520.00 | -59,570.00 | -7,503,512.00 | 0.00 | |||||||||||
Stock-Based Compensat... | 0.00 | 3.05M | 0.00 | 0.00 | 0.00 | 2.78M | 26.16M | 0.00 | |||||||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | -5,954,500.00 | -14,474,300.00 | -23,146,300.00 | -39,128,788.00 | 5.93M | -38,910,872.00 | -29,252,467.00 | 24.71M | |||||||||||
Accounts Payables | 0.00 | -8,562,600.00 | 14.64M | 17.31M | -2,683,751.00 | 41.10M | 33.38M | -96,082,969.00 | |||||||||||
Inventory | -3,720,200.00 | -5,214,023.73 | -7,456,124.44 | -9,271,643.28 | -43,312,793.60 | -17,018,567.35 | -51,134,998.39 | 41.34M | |||||||||||
Other Working Capital | 10.98M | -22,345,699.62 | -8,662,297.72 | 818.28k | -2,668,520.47 | -59,570.35 | -7,503,512.54 | 1.00 | |||||||||||
Other Non-Cash Items | 2.15M | 11.85M | 72.89k | 5.06M | 35.56M | 9.68M | 94.04M | 144.29M | |||||||||||
Net Cash Provided By Op... | 36.31M
+0% |
23.60M
-35% |
57.93M
+145% |
67.24M
+16% |
63.79M
-5% |
255.42M
+300% |
152.55M
-40% |
-37,249,857.00
-124% |
|||||||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | -9,027,423.58 | -10,817,365.60 | -10,530,329.06 | -26,292,969.80 | -82,836,538.59 | -79,506,037.18 | -176,848,588.75 | -128,644,463.00 | |||||||||||
Acquisitions Net | 9.03M | 200.00k | 0.00 | 26.29M | 43.09k | 0.18 | 541.00k | 0.00 | |||||||||||
Purchases Of Investments | -1,000,000.00 | 0.00 | 0.00 | -3,750,000.00 | -805,000,000.00 | -18,363,262.39 | -179,925,000.00 | -4,291,667.00 | |||||||||||
Sales Maturities Of Inve... | 1.05M | 249.95k | 1.58M | 10.36M | 8.98M | 6.30M | 7.07M | 758.68k | |||||||||||
Other Investing Activities | -9,027,423.58 | 200.00k | 0.14 | -26,292,968.89 | 805.00M | -335,000,000.00 | 159.21M | 65.95M | |||||||||||
Net Cash Used For Inv... | -8,974,926.08
+0% |
-10,367,414.95
+16% |
-8,952,056.92
-14% |
-19,681,837.69
+120% |
-73,815,765.91
+275% |
-426,565,879.39
+478% |
-189,947,602.55
-55% |
-66,227,333.00
-65% |
|||||||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 58.79M | 365.55M | |||||||||||
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | -856,242.00 | -20,386,836.00 | 0.00 | 0.00 | |||||||||||
Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
Dividends Paid | 0.00 | -28,000,000.00 | -28,000,000.00 | -7,000,000.00 | -45,000,000.00 | -18,038,700.00 | -99,814,140.00 | -12,943,593.00 | |||||||||||
Other Financing Activities | 0.00 | 45.05M | 62.10M | 216.28M | -1,225,975.00 | 158.68M | -12,823,555.00 | -19,483,487.00 | |||||||||||
Net Cash Used/Provide... | 0.00
+0% |
17.05M
+0% |
34.10M
+100% |
209.28M
+514% |
-46,225,975.00
-122% |
140.64M
-404% |
-53,847,695.76
-138% |
333.13M
-719% |
|||||||||||
Effect Of Forex Changes... | 573.42 | -25,405.98 | 560.56k | 797.12k | -10,277,579.69 | -4,501,528.55 | -809,008.10 | 4.92M | |||||||||||
Net Change In Cash | 27.34M | 30.26M | 83.64M | 257.64M | -66,525,461.00 | -35,004,818.00 | -92,049,775.00 | 234.57M | |||||||||||
Cash At Beginning Of Per... | 41.88M | 69.22M | 99.48M | 183.12M | 440.76M | 374.24M | 339.23M | 247.18M | |||||||||||
Cash At End Of Period | 69.22M | 99.48M | 183.12M | 440.76M | 374.24M | 339.23M | 247.18M | 481.75M | |||||||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | 36.31M | 23.60M | 57.93M | 67.24M | 63.79M | 255.42M | 152.55M | -37,249,857.00 | |||||||||||
Capital Expenditure | -9,027,423.58 | -10,817,365.60 | -10,530,329.06 | -26,292,969.80 | -82,836,538.59 | -79,506,037.18 | -176,848,588.75 | -128,644,465.00 | |||||||||||
Free Cash Flow | 27.29M
+0% |
12.79M
-53% |
47.40M
+271% |
40.95M
-14% |
-19,042,678.59
-147% |
175.92M
-1,024% |
-24,294,057.75
-114% |
-165,894,316.17
+583% |